Contents of Next Issues · Themenvorschau
Peter Thuss‐Patience(Charité - Universitätsmedizin Berlin), R. Sauer, R. Linke, B. Schymura, R. Schwarz, Peter Burfeind(Universitätsmedizin Göttingen), Claus Rödel(Goethe University Frankfurt), P. Tanswell(Boehringer Ingelheim (Germany)), Ulrich Kunz(Boehringer Ingelheim (Germany)), T. Brunner, G. Egerer, D.H.J. Jager(Krankenhaus Nordwest), Susanne Singer(Rostock University of Music and Theatre), Felix J. Hartmann(German Cancer Research Center), U. Aydemir, E. Dühmke, Hartmut Kuthan(Boehringer Ingelheim (Germany)), M. Lenk, V. Viereck, A. Amelsberg(Boehringer Ingelheim (Germany)), G. Hartung, P. Herschbach, P. Reichardt, H Sommer, Hartmut Goldschmidt(Heidelberg University), G. Emons, S. Sehlen, G. Niedobitek, R.D. Hofheinz, Reinhold Tiling, T. Krauss, A. Engert, Salah‐Eddin Al‐Batran(Goethe University Frankfurt), Kirsten Brinkbäumer, C Renner, M. Keßler, Sven Fuchs(BOKU University), Veit Krenn(Max Planck Society), Kai Hübel(University Hospital Cologne), H. Hollenhorst, E. Heissen, A. Schmitt, B. Dörken, Albrecht Kretzschmar(Roche (Switzerland)), A. D. Ho, C. Harter, H. Iro, G. Stehle(Boehringer Ingelheim (Germany)), Meinolf Karthaus(Evangelisches Krankenhaus Bielefeld), Michael Untch(Helios Kliniken)
Cited by 1
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k